Metraipolis › archive › dc_b5ea71046f99
Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteers — Europe PMC PMID:41705834
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41705834
- DOI
- 10.1128/aac.01315-25
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T16:42:31.605Z
- SHA-256 of the archived text
fb87b6bd5a4211f3a75cfb656daa44a95395ae9e6bfad3fbefe7fe466610e8e8- Stable URL of this page
https://metraipolis.com/documento/dc_b5ea71046f99
How to cite
Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteers — Europe PMC PMID:41705834 — Europe PMC (en), https://europepmc.org/article/MED/41705834 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b5ea71046f99 (Metraipolis archive dc_b5ea71046f99, sha256 fb87b6bd5a4211f3a75cfb656daa44a95395ae9e6bfad3fbefe7fe466610e8e8)
BibTeX
@misc{dcb5ea71046f99,
title = {Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteers — Europe PMC PMID:41705834},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41705834},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b5ea71046f99; sha256 fb87b6bd5a4211f3a75cfb656daa44a95395ae9e6bfad3fbefe7fe466610e8e8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41705834. Agents can read the archived copy with the MCP tool read_document.